| 标题 |
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Mazen Noureddin; Juan P. Frías; Guy Neff; K. Lucas; Cynthia Behling; et al 出版日期:2025-08-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)